National Influenza Vaccine Modernization Strategy 2020-2030   [open pdf - 905KB]

From the Executive Summary: "An influenza pandemic can occur at any time with little warning; any delay in detecting a novel influenza strain; sharing of influenza virus samples; and in developing, producing, distributing, or administering a therapeutic or vaccine could result in significant additional morbidity and mortality. Vaccination is currently the most effective strategy for preventing influenza infection. While substantial progress has been made in national influenza preparedness and prevention, significant gaps remain: domestic influenza vaccine production is inefficient and insufficient, vaccine effectiveness is less than optimal, and vaccination rates across the United States are too low. [...] Accordingly, as directed by the Executive Order (EO) 13887 on Modernizing Influenza Vaccines in the United States to Promote National Security and Public Health, this National Influenza Vaccine Modernization Strategy (NIVMS), 2020-2030, outlines a vision for the United States' influenza vaccine enterprise to be highly responsive, flexible, resilient, scalable, and more effective at reducing the impact of seasonal and pandemic influenza viruses. This vision is supported by three overarching strategic objectives: 1. Strengthen and diversify influenza vaccine development, manufacturing, and supply chain; 2. Promote innovative approaches and use of new technologies to detect, prevent, and respond to influenza; and 3. Increase influenza vaccine access and coverage across all populations."

Public Domain
Retrieved From:
HHS Public Health Emergency: https://www.phe.gov/
Media Type:
Help with citations